Skip to main content

Clinical Trials for Cancer Care 

KRMC’s WL Nugent Cancer Center is the only cancer treatment center in Mohave County to offer clinical trials for cancer. Our facility is partnered with the National Cancer Institute’s Community Oncology Research Program (NCORP), a national network dedicated to bringing cancer clinical trials to people in their own communities.

What is a clinical trial?

Clinical trials are scientific studies that evaluate the effectiveness of new medical treatments, which can include:

• New drugs that have not yet been approved by the Food and Drug Administration (FDA)
• New uses for drugs that are already FDA-approved
• New technologies, such as a new type of radiation therapy
• New ways to combine treatments

After a new medical treatment is thoroughly tested for safety, a clinical trial is done to see how the treatment works on real patients. The patient's safety is the top priority in all phases of clinical trials. When a patient volunteers for a clinical trial, their doctor will determine if it is safe and appropriate for their condition. If so, they can enroll and begin the treatment. 

Researchers compare data from clinical trials to data from the standard treatment, or the treatment currently in use. They will monitor the patient’s condition throughout the trial to see if the new treatment is more effective or improves patient outcomes compared to the standard treatment. If the new treatment shows benefits over the standard treatment, it may go on to become the standard treatment.

Clinical trials can offer cancer patients the opportunity to try the newest and most advanced treatments in medical science, which are not yet available to the public. This research also benefits future patients.

Who can participate in clinical trials?

To participate in a clinical trial, a patient must meet certain criteria specific to that trial. For example, a trial could be limited to people of a certain age or with a particular medical condition. This is to make sure that only people who can safely take part in the clinical trial are included.

The patient, their doctor, and the research team will discuss benefits and any risks of a given trial to determine whether it is appropriate for the patient. All trials are voluntary. Patients may discontinue a trial at any time and will still receive the best possible care for their condition.

What trials are available?

The WL Nugent Cancer Center is currently recruiting patients with various conditions for clinical trials.

Addressing Cancer Health Disparities

Advanced Melanoma

Advanced Unresectable Melanoma

Anal Cancer

Blood and Tissue Donation for Cancer Research

Blood Donation to Improve Early Detection of Cancer

Cancer Drug Shortages

Cancer Patients who Contract COVID-19

Cancer Patients Who Smoke

Cancer Related Sleep Problems

Cancer Survivors and Caregivers

Colorectal Cancer

Colorectal Cancer with Deficient DNA Mismatch Repair

Head and Neck Cancer Survivors

HER2-positive Breast Cancer

HER2-positive Breast Cancer with Residual Disease

Lung Cancer

Lung Cancer in Adults over Age 70

Lymphocytic Leukemia in Older Patients

Lymphocytic Leukemia in Younger Patients

Molecular Analysis for Therapy Choice (MATCH) for Non-Responsive or Rare Cancers

Neuroendocrine Tumors

Pancreatic Cancer

Pancreatic Cancer in Adults over Age 70

Patients on Immune Checkpoint Inhibitors

Prostate Cancer

Prostate Cancer Survivors

Smoldering (Pre-Cancerous) Myeloma

Squamous Cell Skin Cancer

Upper Urinary Tract Cancer

Please talk to your doctor if you think a clinical trial may be right for you.


Patient Resources

At WL Nugent Cancer Center we offer a range of services to make your treatment and follow-up care as comfortable and successful as possible.  

Am I Eligible for a Clinical Trial?

KRMC's WL Nugent Cancer Center is the only cancer treatment center in Mohave County to offer clinical trials for cancer
meet them

Meet our Physicians

Our oncologist at WL Nugent Cancer Center have years of experience and expertise in medical oncology, radiation oncology, and hematology